ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993